In vivo effects of maternal immunosupression during pregnancy on the immune function of newborn infants

Arhiv za Higijenu Rada i Toksikologiju

Volumn 56, Issue 2, 2005, Pages 151-156

  Meregalli, Elisa ^a   Biggioggero, Martina ^a   Borghi, Orietta ^b   Meroni, Pierluigi ^b   Cimaz, Rolando ^a  

^a ICP   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cyclosporine A; Dexamethasone; Immune function; Immunosuppressants; Newborns; Vaccination

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; HEPATITIS B VACCINE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PREDNISONE;

ANEMIA; BLOOD PLACENTA BARRIER; CLINICAL ARTICLE; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EVALUATION; FEMALE; FETUS CIRCULATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE FUNCTION TEST; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MATERNAL DISEASE; NEWBORN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PSORIATIC ARTHRITIS; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VACCINATION;

CONNECTIVE TISSUE DISEASES; FEMALE; FETUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-2; MALE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 19944394511     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Di Paolo S, Schena A, Morrone LF; Manfredi G, Stallone G, Derosa G, Procino A, Schena FP. Immunological evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipient. Trasplantation 2000;69:2049-54.
2. Cimaz R, Meregalli E, Biggioggero M, Borghi O, Tincani A, Motta M, Airo P, Meroni PL. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. Toxicol Lett 2004;149:155-62.
3. Little BB. Immunosuppressant therapy during gestation. Seminars Perinatol 1997;21:143-8.
4. Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy. Rheum Dis Clin North Am 1997;23:149-67.
5. Armenti VT, Moritz MJ, Davison JM. Drug safety issues in pregnancy following transplantation and immunosuppression. Effects and outcomes. Drug Safety 1998;19:219-32.
6. Ostensen M, Ramsey-Goldman R. Treatment of inflammatory rheumatic disorder in pregnancy. Drug Safety 1998;19:390-410.
7. Janssen NM, Genta M, 2000. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation. Arch Int Med 2000;160:610-9.
8. Harris EN. Antirheumatic drugs in pregnancy. Lupus 2002;11:683-9.
9. Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drug: experimental and clinical studies. Pediatr Nephrol 2002;17:121-30.
10. Petri M. Immunosoppressive drug use in pregnancy. Autoimmunity 2003,36;51-6.
11. Takahashi N, Nishida H, Hoshi J. Severe B cell depletion in newborns from renal transplant mothers taking immunosuppressive agents. Transplantation 1994;57:1617-21.
12. Ersay A, Oygür N, Cpskun M, Süleymanlar G, Track B, Yegin O. Immunologic evaluation of a neonate born to an immunosuppressed kidney transplant recipient. Am J Perinatol 1995;12:413.
13. Kozlowska-Boszko B, Korczak G, Wierzbicki P, Lis K, Gaciong Z, Lao M, Sicinska J, Gorski A. Pregnancy following kidney transplantation: risk for offsprings. Trasplantation Proc 1997;29:262-5.
14. Flechner SM, Kartz AR, Rogers AJ, Van Buren C, Kahan BD. The presence of cyclosporine in body tissues and fluids during pregnancy. Am J Kidney 1985;5:60-3.
15. Venkataramanan R, Koneru B, Wang CCP, Burckart GJ, Caritis SN, Starzl TE. Cyclosporine and its metabolites in mother and baby. Transplantation 1988;46:468.
16. Kosugi A, Zuniga-Pflunker JC, Sharrow SO, Krulabeek AM, Sheerer GM. Effect of cyclosporin A on lymphopoiesis. Developmental effects on immature thymocytes in fetal thymus organ culture treated with cyclosporin. Am J Immunol 1989;143:3134-40.
17. Rose ML, Dominguez M, Levare N. Analysis of T-cell subpopolations and cyclosporine levels in the blood of two neonates born to immunosuppressed heart-lung transplant recipients. Transplantation 1989;48:223-6.
18. Nandakumaran M, Eldeen AS. Transfer of cyclosporine in the perfused human placenta. Dev Pharmcol Ther 1990;15:101-5.
19. Arellano F, Monka C, Krupp P. Treatment with cyclosporine A in pregnancy. Med Clin 1991;96:194.
20. Baarsma R, Kamps WA. Immunological responses in an infant after cyclosporine A exposure during pregnancy. Eur J Pediatr 1993;152:476-7.
21. Armenti VT, Ahlswede KM, Ahlwede BA. Variables affecting birth weight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1995;59:476-9.
22. Rezzani R, Rodella L, Bianchi R. Cyclosporine and pregnancy in the rat. Trasplantation 1997;63:164-7.
23. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001;71:1051-5.
24. Jain A, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, Warty V, Stand TE. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997;64:559-65.
25. Kainz A, Harabacz I, Cowlrick IS, Shirikant DG, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000;70:1718-21.
26. Thitu Y, Bateman DN, Coulthard MG. Successful breast feeding while mother was taking cyclosporine. BMJ 1997;315:463.
27. Nyberg G, Haljamäe U, Frisenette-Fich C, Wennergren M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Trasplantation 1998;65:253-5.
28. Padgett EL, Seeling LL Jr. Effects on T-cell maturation and proliferation induced by lactational transfer of cyclosporine to nursing pups. Transplantation 2002;73:867-74.
29. Pilarski LM, Yacyshyn BR, Lazarovits AI. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Trasplantation 1994;57:133-44.
30. Prevot A, Martini S, Guighard JP. In utero exposure to immunosuppressive drugs. Biol Neonate 2002;81:73-81.
31. Airò P Antonioli CM, Motto M, Faden D, Chirico G, Cattaneo R, Tincani A. The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis. Lupus 2002;11:454-7.
32. Coté CJ, Meuwissen HG, Pickering RJ. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 1974;85:324-8.
33. Cederqvist LL, Merkatz IR, Litwin SD. Fetal immunoglobulin synthesis following maternal immunosuppression. Am J Obstet Gynecol 1997;129:687-90.
34. DeWitte DB, Buick MK, Cyran SE. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr 1984;105:625-8.
35. Davidson JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed hemopoiesis in the babies of renal allograft patients. Br J Obstet Gynecol 1985;92:233-9.
36. Classen JB, Shevach EM. Evidence that cyclosporine treatment during pregnancy predisposes offspring to develop autoantibodies. Transplantation 1991;51:1052-7.
37. Classen JB. Cyclosporine induced autoimmunity in newborns prevented by early immunization. Autoimmunity 1998;27:135-9.
38. Holladay SD. Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ Health Perspect 1999;107:687-91.
39. Hess AD, Horwitz I, Beschorner WE, Santos GW. Development of a graft-versus-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantations. Development of cytotoxic T lymphocytes with apparent polyclonal anti-La specificity, including autoreactivity. J Exp Med 1985;161:718-24.
40. Scott JR. Risks to the children born to mothers with autoimmune disease. Lupus 2002;11:655-60.
41. Hess AD, Fischer AC, Beschorner WE. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets. J Immunol 1990;145:526-33.
42. Von Hertzen LC. Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J All Clin Immunol 2002;109:923-8.
43. Chaouat G, Diallo JT, Volumenie JL, Menu E, Gras G, Delage G, Mognetti B. Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann. AJRI 1997;37:427-34.
44. Gitau R, Cameron A, Fisk NM, Glover V. 1998. Fetal exposure to maternal cortisol. Lancet 1998;352:707-8.